Literature DB >> 12579625

Measuring health-related quality of life in women with urogenital dysfunction: the urogenital distress inventory and incontinence impact questionnaire revisited.

C Huub van der Vaart1, J Rob J de Leeuw, Jan-Paul W R Roovers, A Peter M Heintz.   

Abstract

AIMS: Symptoms of urogenital dysfunction are known to negatively affect health-related quality of life in women. To assess effectiveness of treatment, it is currently recommended to include measurements of quality of life in outcome analysis. One of the questionnaires that is commonly used is the combination of the Urogenital Distress Inventory (UDI) and Incontinence Impact Questionnaire (IIQ). Unfortunately, the validity of the UDI and IIQ has only been tested in highly selected subgroups of female patients. Therefore, it is unclear whether this questionnaire is suitable for use in populations with different characteristics.
METHODS: We analyzed the scale construction and validity of the UDI and IIQ in a random sample of 2,042 women, aged 20-70 years old and a clinical sample of 196 women.
RESULTS: Our results show that the UDI can be divided into five subscales, namely discomfort/pain, urinary incontinence, overactive bladder, genital prolapse, and obstructive micturition. The internal consistency (Cronbach's alpha) ranged between 0.74 and 0.82. In addition to the original four subscales of the IIQ (mobility, physical, social, and emotional functioning), we identified a fifth subscale with four items about embarrassment. Internal consistency of these subscales ranged between 0.83 and 0.93. In addition to the internal consistency, we tested the criterion and construct validity of these new subscale division.
CONCLUSIONS: We found these subscales to be reliable and of clinical use. It is recommended to use the revised UDI and IIQ in outcome analysis of treatments for urogenital symptoms in women. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12579625     DOI: 10.1002/nau.10038

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  85 in total

1.  The prevalence of voiding difficulty after TVT, its impact on quality of life, and related risk factors.

Authors:  Harry A M Vervest; Tanya M Bisseling; A Peter M Heintz; Steven E Schraffordt Koops
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-22

2.  The effect of vaginal and cesarean delivery on lower urinary tract symptoms: what makes the difference?

Authors:  Henriette Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-21

3.  Defecatory symptoms during and after the first pregnancy: prevalences and associated factors.

Authors:  H Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-08-03

4.  Does vaginal reconstructive surgery with or without vaginal hysterectomy or trachelectomy improve sexual well being? A prospective follow-up study.

Authors:  Jackie A Stoutjesdijk; Mark E Vierhout; Johan W M Spruijt; Elske T Massolt
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-16

5.  The effectiveness of the sacrospinous hysteropexy for the primary treatment of uterovaginal prolapse.

Authors:  Viviane Dietz; Joyce de Jong; Marieke Huisman; Steven Schraffordt Koops; Peter Heintz; Huub van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-24

Review 6.  Urinary symptoms in breast cancer: a systematic review.

Authors:  Kristine A Donovan; Alice R Boyington; Roohi Ismail-Khan; Jean F Wyman
Journal:  Cancer       Date:  2011-07-12       Impact factor: 6.860

7.  Medium-term efficacy of pelvic floor muscle training for female urinary incontinence in daily practice.

Authors:  B H C Lamers; C H van der Vaart
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-06-22

8.  Clinical-decision taking in primary pelvic organ prolapse; the effects of diagnostic tests on treatment selection in comparison with a consensus meeting.

Authors:  Annette G Groenendijk; Erwin Birnie; Sjoerd de Blok; Albert H Adriaanse; Willem M Ankum; Jan-Paul W Roovers; Gouke J Bonsel
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-10

9.  Four-defect repair in women with symptomatic anterior compartment prolapse: a large cohort study.

Authors:  S D Thys; D de Ridder; W Everaerts; S van Bruwaene; J Deprest; J P Roovers
Journal:  Int Urogynecol J       Date:  2014-04-26       Impact factor: 2.894

10.  Validity, reliability and responsiveness of a Dutch version of the prolapse quality-of-life (P-QoL) questionnaire.

Authors:  Filip Claerhout; Philip Moons; Sophie Ghesquiere; Jasper Verguts; Dirk De Ridder; Jan Deprest
Journal:  Int Urogynecol J       Date:  2010-01-16       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.